Edition:
United Kingdom

People: Ajanta Pharma Ltd (AJPH.NS)

AJPH.NS on National Stock Exchange of India

1,019.25INR
20 Jul 2018
Change (% chg)

Rs45.30 (+4.65%)
Prev Close
Rs973.95
Open
Rs965.00
Day's High
Rs1,027.50
Day's Low
Rs950.60
Volume
615,992
Avg. Vol
352,519
52-wk High
Rs1,595.00
52-wk Low
Rs895.85

Agrawal, Rajesh 

Mr. Rajesh M. Agrawal is Joint Managing Director, Director of Ajanta Pharma Limited. He is graduate in Business Studies from University of Buckingham, UK and MBA from Bentley College, USA, he joined the company in 1999. He has transformed Ajanta's domestic business to one of the best performing market for the company. Under his leadership, Ajanta has emerged as a speciality focussed company, especially in India and has improved its rank in the domestic market significantly. His keen focus on new products and strategizing has made Ajanta a leading player in the segments of cardiology, dermatology and ophthalmology in a very short period. Most of the new product launches, being first of its kind in the Indian market are credited to his business acumen. He has also replicated this success in the Philippines, where the Ajanta Pharma Philippines features amongst the fastest growing companies in that country for over three years.

Basic Compensation

Total Annual Compensation, INR 13,132,800
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 13,132,800

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Mannalal Agrawal

15,140,000

Madhusudan Agrawal

17,052,800

Gaurang Shah

--

Rajesh Agrawal

13,132,800

Yogesh Agrawal

17,052,800

Purushottam Agrawal

17,052,800
As Of  31 Mar 2015